Oliveira Bianca T M, Bitencourt Tamires A, Santos Patrick, Pagano Antônio D, Pessoni André M, Rezende Caroline P, Piraine Renan A, Masson Ana P, Faça Vitor, Campos Vinicius F, Alves Lysangela R, Colombo Arnaldo L, Almeida Fausto
Departament of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Structural Genomics Laboratory, Technological Development Center, Federal University of Pelotas, Pelotas, Brazil.
Comput Struct Biotechnol J. 2025 Apr 15;27:1887-1900. doi: 10.1016/j.csbj.2025.04.014. eCollection 2025.
comprises a group of pathogenic fungi with notable resistance to antifungal treatments and diagnostic challenges. The variety is of particular clinical importance due to its multidrug resistance and association with invasive infections, particularly in immunocompromised patients such as diabetics and neonates. Moreover, it has been implicated in hospital outbreaks, posing a significant challenge for infection control and antifungal treatment. Extracellular vesicles (EVs) released by these fungi play critical roles in pathogen-host interactions, potentially influencing antifungal resistance, immune evasion, and virulence. Previous studies conducted by our group have demonstrated that EVs carry immunogenic cargo that can influence the host's immune response. A comprehensive understanding of the molecular composition of these EVs is crucial for unraveling the mechanisms that govern resistance and virulence in var. . This study characterizes the proteomic and miRNA-like cargo of EVs from var. , revealing components that contribute to its adaptation and survival mechanisms. Proteomic analysis identified 124 EV-specific proteins, including BMH1, TEF1, CDC19, and PDC11, which are linked to processes such as metabolic adaptation, cell wall remodeling, and biofilm formation. miRNA-like molecules associated with mitochondrial function, such as the electron transport chain and regulation of the citric acid cycle, were also detected. These findings provide insights into EV-mediated molecular mechanisms driving fungal pathogenesis and resistance. By characterizing the EV cargo, this study highlights potential targets for antifungal therapies and offers a framework for understanding EV roles in fungal adaptation and pathogenicity.
The complex poses significant clinical challenges due to its intrinsic resistance to conventional antifungal therapies and diagnostic complexities. This research explores the cargo of EVs released by var. , revealing a selective mechanism for exporting proteins and RNA molecules critical to the fungus' adaptation and survival in diverse environments. Proteomic and RNA analyses identified molecules involved in metabolic reprogramming, immune modulation, and stress response. These findings highlight the role of EVs in mediating host-pathogen interactions, facilitating immune evasion, and contributing to fungal virulence. Understanding the EV cargo expands our knowledge of fungal biology and underscores the therapeutic potential of targeting EV-associated molecules in antifungal strategies.
由一组对抗真菌治疗具有显著抗性且诊断具有挑战性的致病真菌组成。由于其多药耐药性以及与侵袭性感染的关联,尤其是在糖尿病患者和新生儿等免疫功能低下的患者中,该种类具有特别重要的临床意义。此外,它还与医院感染爆发有关,对感染控制和抗真菌治疗构成重大挑战。这些真菌释放的细胞外囊泡(EVs)在病原体与宿主的相互作用中起关键作用,可能影响抗真菌耐药性、免疫逃逸和毒力。我们团队之前进行的研究表明,EVs携带可影响宿主免疫反应的免疫原性物质。全面了解这些EVs的分子组成对于揭示控制该变种耐药性和毒力的机制至关重要。本研究对来自该变种的EVs的蛋白质组和类似miRNA的物质进行了表征,揭示了有助于其适应和生存机制的成分。蛋白质组分析鉴定出124种EV特异性蛋白质,包括BMH1、TEF1、CDC19和PDC11,它们与代谢适应、细胞壁重塑和生物膜形成等过程相关。还检测到与线粒体功能相关的类似miRNA的分子,如电子传递链和柠檬酸循环的调节。这些发现为EV介导的驱动真菌发病机制和耐药性的分子机制提供了见解。通过表征EV物质,本研究突出了抗真菌治疗的潜在靶点,并为理解EV在真菌适应和致病性中的作用提供了框架。
该复合体因其对传统抗真菌治疗的固有抗性和诊断复杂性而构成重大临床挑战。本研究探索了该变种释放的EVs的物质,揭示了一种选择性机制,用于输出对真菌在不同环境中的适应和生存至关重要的蛋白质和RNA分子。蛋白质组和RNA分析鉴定出参与代谢重编程、免疫调节和应激反应的分子。这些发现突出了EVs在介导宿主 - 病原体相互作用、促进免疫逃逸和促成真菌毒力方面的作用。了解EV物质扩展了我们对真菌生物学的认识,并强调了在抗真菌策略中靶向与EV相关分子的治疗潜力。